We are an innovative medical device company focused on the development and delivery of biomaterials for the medical field. Since 1992, we have introduced ground-breaking products in the areas of hemostasis and wound healing to support healthcare providers and their patients.
These revolutionary products are based on the isolation, characterization and formulation of our novel and proprietary polysaccharide polymer (pGlcNAc).
To enhance the lives of patients and support healthcare providers through the use of innovative healthcare technologies.
To lead our talented, dedicated employees, a strong management team is essential to implement our strategic growth plan.
Indications for Use:
SyvekNT® is intended for the promotion of rapid control of bleeding in patients following hemodialysis and in patients on anticoagulation therapy. SyvekNT is intended for use in the local management of bleeding wounds such as vascular access site, percutaneous catheters or tubes and surgical debridement. Syvek Excel® is intended for use following femoral vascular catheterization procedures to assist in obtaining and maintaining hemostasis.
PRECAUTIONS: There are no known contraindications to the use of SyvekNT®. Longer compression may be necessary for hypertensive or obese patients. There are no known contraindications to the use of Syvek Excel®. Longer compression may be necessary for hypertensive or obese patients.
Not made with Natural Rubber Latex
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician or other licensed practitioner.
Manufactured by Marine Polymer Technologies, Inc., Danvers, MA 01923. For instructions for use or additional product information, please contact us.